Chronic kidney disease (CKD) has emerged as a silent yet deadly threat, claiming its place among the top 10 causes of death worldwide. This alarming trend is a wake-up call for global health initiatives.
In 2023, CKD accounted for a staggering 1.48 million deaths globally, a significant increase from previous years. The disease's prevalence has skyrocketed, affecting an estimated 788 million people aged 20 and above across 204 countries. This rise in numbers has pushed CKD into the spotlight, highlighting its impact on global health.
But here's where it gets controversial: despite advancements in evidence-based therapies, CKD continues to rise. Researchers attribute this to a combination of factors, including vascular risks, genetic variants, and even climate change.
Dr. Patrick B. Mark, from the University of Glasgow, emphasizes the urgency of the situation: "CKD is a major health issue, and we need to address it head-on."
And this is the part most people miss: CKD is not just about kidney health. It's a complex disease with far-reaching consequences. Impaired kidney function is a significant risk factor for cardiovascular disease, another leading cause of death worldwide. In fact, kidney dysfunction ranks as the seventh-highest risk factor for cardiovascular deaths, surpassing high fasting plasma glucose and BMI.
The data paints a clear picture: CKD is a global epidemic, with the highest prevalence seen in regions like North Africa, the Middle East, and South Asia. China leads the way with 152 million individuals affected, followed by India with 138 million. Even the US reports a significant number, with 38.3 million people living with CKD.
But the impact of CKD goes beyond numbers. It's a disease that disproportionately affects older adults, with more severe stages prevalent in this demographic. The need for kidney replacement therapies, such as dialysis and transplants, rises with age, putting a strain on healthcare systems worldwide.
Dr. Valerie A. Luyckx and Dr. Ifeoma I. Ulasi, in an accompanying comment, urge the global nephrology community to take action: "We must raise awareness, integrate CKD into primary care, and support clinicians to implement guideline-directed therapy."
The study, published in The Lancet, utilized various data sources, including literature, registration systems, and household surveys. The researchers estimated CKD burden, deaths, and risk factors using advanced analytical tools.
However, the data is not without its limitations. Dr. Luyckx and Dr. Ulasi highlight the lack of accurate data in certain regions, especially regarding albuminuria, which may have impacted the findings.
"Accurate data is crucial for effective policy-making," they emphasize. "We must collect comprehensive data from lower socioeconomic regions to address these inequities."
So, what can we do to tackle this global health crisis? The answer lies in collaboration and awareness. By raising awareness, integrating CKD into primary care, and collecting accurate data, we can work towards a future where CKD is no longer a leading cause of death.
